Ignite Creation Date:
2024-05-05 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006290
Status:
COMPLETED
Last Update Posted:
2008-09-25
First Post:
2000-09-21
Brief Title:
Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Study Overview
Official Title:
Perceived Changes in Body Habitus and Body Image Among HIV Persons Currently Receiving or Recently Discontinuing Combination Antiretroviral Therapy
Status:
COMPLETED
Status Verified Date:
2003-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to learn how changes in body build affect the lives of people taking anti-HIV medications By learning this a set of questions can be created to help understand how changes in body build and image affect people living with HIV infection
A set of questions used to measure body image might be useful in future HIV studies It may help doctors understand patient concerns about their body image and why some patients stop taking their anti-HIV medications
A set of questions used to measure body image might be useful in future HIV studies It may help doctors understand patient concerns about their body image and why some patients stop taking their anti-HIV medications
Detailed Description:
A valid measure of body image would be useful for AACTG studies Such a measure might permit investigators to examine dissatisfaction with body image as a predictor variable in analyses of premature study drug discontinuation loss to follow-up and study drug non-adherence and as a secondary outcome in antiretroviral and fat redistribution treatment trials
Six focus group interviews each lasting approximately 2 hours are conducted at 4 AACTG sites Separate groups are run for men and women and male groups are segmented by sexual orientation A moderator leads discussions about patients perceived changes in body habitus and body image Group interviews are audio-taped and transcribed verbatim Qualitative interview data are sent electronically to the Data Management Center where they are thematically analyzed using qualitative data analysis content analysis techniques Salient focus group findings are used to construct questionnaire items
Six focus group interviews each lasting approximately 2 hours are conducted at 4 AACTG sites Separate groups are run for men and women and male groups are segmented by sexual orientation A moderator leads discussions about patients perceived changes in body habitus and body image Group interviews are audio-taped and transcribed verbatim Qualitative interview data are sent electronically to the Data Management Center where they are thematically analyzed using qualitative data analysis content analysis techniques Salient focus group findings are used to construct questionnaire items
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| AACTG A5089 | None | None | None |